894 related articles for article (PubMed ID: 27623766)
1. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
Prasad CP; Chaurasiya SK; Guilmain W; Andersson T
J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766
[TBL] [Abstract][Full Text] [Related]
2. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
3. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
4. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
[TBL] [Abstract][Full Text] [Related]
5. CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial-mesenchymal transition and suppressing apoptosis through AKT pathway.
Xu B; Zhou M; Qiu W; Ye J; Feng Q
Cancer Med; 2017 May; 6(5):1062-1071. PubMed ID: 28378417
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells.
Park NR; Cha JH; Jang JW; Bae SH; Jang B; Kim JH; Hur W; Choi JY; Yoon SK
Biochem Biophys Res Commun; 2016 Sep; 477(4):568-574. PubMed ID: 27320862
[TBL] [Abstract][Full Text] [Related]
7. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
8. Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer.
Wang B; Tang Z; Gong H; Zhu L; Liu X
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054966
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W
Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723
[TBL] [Abstract][Full Text] [Related]
10. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
Sun G; Liu M; Han H
J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
[TBL] [Abstract][Full Text] [Related]
12. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
[TBL] [Abstract][Full Text] [Related]
13. PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer.
Juang YL; Jeng YM; Chen CL; Lien HC
Mol Carcinog; 2016 Dec; 55(12):2247-2259. PubMed ID: 26824226
[TBL] [Abstract][Full Text] [Related]
14. Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms.
Wang L; Wu H; Wang L; Zhang H; Lu J; Liang Z; Liu T
Cancer Lett; 2017 Jul; 398():24-36. PubMed ID: 28400334
[TBL] [Abstract][Full Text] [Related]
15. Wnt5A and TGFβ1 Converges through YAP1 Activity and Integrin Alpha v Up-Regulation Promoting Epithelial to Mesenchymal Transition in Ovarian Cancer Cells and Mesothelial Cell Activation.
Dehghani-Ghobadi Z; Sheikh Hasani S; Arefian E; Hossein G
Cells; 2022 Jan; 11(2):. PubMed ID: 35053353
[TBL] [Abstract][Full Text] [Related]
16. COX-2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis.
Majumder M; Xin X; Liu L; Tutunea-Fatan E; Rodriguez-Torres M; Vincent K; Postovit LM; Hess D; Lala PK
Stem Cells; 2016 Sep; 34(9):2290-305. PubMed ID: 27301070
[TBL] [Abstract][Full Text] [Related]
17. MiR-154 Functions as a Tumor Suppressor in Glioblastoma by Targeting Wnt5a.
Zhao D; Wang R; Fang J; Ji X; Li J; Chen X; Sun G; Wang Z; Liu W; Wang Y; Cheng G; Zhen H; Sun C; Fei Z
Mol Neurobiol; 2017 May; 54(4):2823-2830. PubMed ID: 27013470
[TBL] [Abstract][Full Text] [Related]
18. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB
Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394
[TBL] [Abstract][Full Text] [Related]
19. SWI/SNF chromatin-remodeling factor Smarcd3/Baf60c controls epithelial-mesenchymal transition by inducing Wnt5a signaling.
Jordan NV; Prat A; Abell AN; Zawistowski JS; Sciaky N; Karginova OA; Zhou B; Golitz BT; Perou CM; Johnson GL
Mol Cell Biol; 2013 Aug; 33(15):3011-25. PubMed ID: 23716599
[TBL] [Abstract][Full Text] [Related]
20. Twist induces epithelial-mesenchymal transition and cell motility in breast cancer via ITGB1-FAK/ILK signaling axis and its associated downstream network.
Yang J; Hou Y; Zhou M; Wen S; Zhou J; Xu L; Tang X; Du YE; Hu P; Liu M
Int J Biochem Cell Biol; 2016 Feb; 71():62-71. PubMed ID: 26693891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]